DNA, RNA, AND PROTEIN

Trusted provider of PCR and NGS

We specialize in molecular analysis laboratory services for drug development and advanced therapies, with expertise in qPCR, dPCR, NGS, and quantitative proteomics. Our proficiency ensures precise genomic and transcriptomic insights to support every stage of therapeutic development.
GLP accredited qPCR and dPCR CRO TATAA Biocenter
Nucleic acid experts

Our technologies

We optimize and validate the entire workflow, from raw tissue specimens to the final data, ensuring the highest quality results are delivered.

NGS Services TATAA Biocenter
RNA-seq

We offer RNA sequencing solutions for total RNA and mRNA-seq analysis, as well as tag-based approaches like 3’-mRNA sequencing and small RNA-seq. These methods help identify biomarkers, reveal therapeutic targets, analyze drug response and resistance, elucidate mechanisms of action, assess immune response, and support various other applications.

DNA-seq

Through various DNA-seq applications, we simultaneously sequence the whole genome, exome, or targeted panels to reveal genetic variations, discover drug targets, understand disease mechanisms, stratify patients, and identify predictive or prognostic biomarkers, all at the DNA level.

PCR Analysis TATAA Biocenter
qPCR/dPCR

We develop and validate dPCR/qPCR assays for biomarker quantification, biodistribution, shedding, and pharmacokinetics in cell and gene therapies. Offering high sensitivity for low-abundance targets across diverse sample types, we support all phases of drug development. Our validated PCR assays for short targets, including siRNA and miRNA, use the Two-Tailed PCR technology.

Olink service provider TATAA Biocenter
Olink proteomics

Olink’s high-throughput, highly multiplex proteomics platform enables the analysis of over 5,400 proteins, or smaller targeted panels, from small sample volumes. This makes it ideal for discovering and validating protein biomarkers associated with disease pathways, therapeutic responses, or safety concerns.

Stay in touch

Sign up for our newsletter

test

"*" indicates required fields

Name*
TWO-Tailed PCR technology

Short RNA quantification with qPCR/dPCR

A TATAA Biocenter innovation that offers validated qPCR/dPCR workflows for siRNA, miRNA, ASOs, and other short nucleic acid targets.

PCR bioanalysis offers several advantages over other methods in speed and throughput; however, standard PCR is unsuitable for short targets due to its length. We have developed a two-tailed primer that enables the optimization, validation, and execution of PCR-based bioanalysis on any short target with high sensitivity and specificity.

Services

Solutions for complex biological challenges

We offer a broad range of tailored commissioned services for drug development programs. With over two decades of expertise in nucleic acid analysis and sample preparation, we optimize workflows by assessing sample quality, validating performance, and analyzing clinical biomarkers using leading, well-matched technologies.

Extraction

Accurate quantification begins with precise extraction

Comprehensive extraction across all sample types and test items

We have extensive experience extracting nucleic acids from various biological samples, including tissues, biofluids, swabs, excreta, secreta, fresh frozen, or FFPE-fixed.

Our expertise covers the extraction of different types of nucleic acids, including DNA, cfDNA, short RNAs (miRNA, siRNA, and more), messenger RNA, and ASOs with diverse modifications and chemical properties.

We consistently include spike-ins to ensure efficient extraction, optimal quality for downstream applications, and the removal of inhibitory agents. Our goal is the accurate quantification of the target molecule, where precise, high-quality extraction is essential for achieving both accuracy and precision.

Primer dimer test Primer-dimers can bias qPCR results, so a test for primer-dimers should be performed during assay development to ensure that only the target sequence is amplified and quantified. The effect of primer dimers Checking for primer dimers is

TCR sequencing TCR sequencing on DNA or RNA is used to understand anti-tumor immune responses and to track responses to infections, vaccinations, and immunotherapies. Our TCR sequencing services Ask a question What is a T-cell receptors (TCRs)? T-cell receptors (TCRs)

Pharmacokinetics (PK) in gene therapies Pharmacokinetics for genes introduced by gene therapies is more challenging than those of finished small molecules. Our custom assays for biodistribution, pharmacokinetics (PK), and shedding. Ask a question Pharmacokinetics (PK) in gene therapies Pharmacokinetics for

About us

The power of our approach

Committed to quality, innovation, and fostering strong client relationships, we serve as your trusted partner to accelerate drug development. As a contract research organization, our mission is to push the boundaries of science and technology to generate accurate and reproducible data that shortens time-to-market.

Regulated laboratory environment

We are GLP accredited for qPCR, dPCR, and molecular biology, GCLP compliant, and ISO/IEC 17025 accredited. Our facility features a strict sample management process, a fully integrated LIMS system, backup for all vital systems, temperature and humidity control, and robust IT security.

Purpose-built PCR laboratory

Our purpose-built laboratory in Gothenburg, Sweden, is specifically designed for PCR. It has controlled air pressure, temporal separation, and biosafety cabinets to minimize contamination risk. This setup enables us to achieve the highest sensitivity and robustness required for validated assays. The lab is equipped with market-leading PCR and NGS instruments and advanced liquid handling systems.

Pioneers in assay development and validation

We are a team of 45 employees, with scientists at the forefront of assay development, optimization, and validation. Our team has co-authored key publications in the field, including Recommendations for Method Development and Validation of qPCR and dPCR Assays in Support of Cell and Gene Therapy Drug Development (AAPS J. 2024) and The MIQE Guidelines for qPCR and dPCR.

Flexible, client-centered solutions

We work closely with our clients to find tailored solutions, offering flexibility in sample types, test items, sample volume, and scalability. We prioritize transparency and proactive communication throughout each project, ensuring our clients are continuously updated on the progress.

contact us

Let's explore how we can support your drug development program

PK/PD​ bioanalysis

One form for all pages, including link to mailchimp.

"*" indicates required fields

×

Olink

"*" indicates required fields

What platform of interest?*
Name*

General Enquiries

Please fill in the form below and we’ll get back to you ASAP.

"*" indicates required fields

Name*

Courses

Please fill in the form for any courses request

"*" indicates required fields

Name*

Sign up to our Newsletter

"*" indicates required fields

Name*

Bioanalytical Services

Please fill in the form below and one of our bioanalytical experts will get back to you ASAP.

"*" indicates required fields

What services are you interested in?*
This field is hidden when viewing the form

Products

Please fill in the form below for any products request

"*" indicates required fields